Published in J Urol on February 01, 2006
Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making (2006) 11.83
Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers. Future Oncol (2016) 0.78
"No Turning Bax" in the combined battle against prostate cancer:. Clin Cancer Res (2007) 0.77
Refining prostate biopsy strategies. J Urol (2006) 0.75
Using the weighted area under the net benefit curve for decision curve analysis. BMC Med Inform Decis Mak (2016) 0.75
Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem (2002) 9.76
An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol (2003) 3.21
Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence. Pharmacol Rev (2004) 3.08
Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med (2004) 2.82
The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int (2009) 2.63
Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology (2006) 2.59
Urinary retention and post-void residual urine in men: separating truth from tradition. J Urol (2008) 2.57
Retrospective drug utilization review, prescribing errors, and clinical outcomes. JAMA (2003) 2.51
Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710. Cancer (2014) 2.48
A boosted Bayesian multiresolution classifier for prostate cancer detection from digitized needle biopsies. IEEE Trans Biomed Eng (2010) 2.41
Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy. Photochem Photobiol (2005) 2.33
The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels. Cancer Cell (2011) 2.12
Minimal tumor volume may provide additional prognostic information in good performance patients after radical prostatectomy. Urology (2007) 2.09
A thorough pelvic lymph node dissection in presence of positive margins associated with better clinical outcomes in radical cystectomy patients. Urology (2009) 2.06
Is ultrasound imaging inferior to computed tomography or magnetic resonance imaging in evaluating renal mass size? Urology (2012) 2.03
The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int (2009) 2.00
Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer. J Urol (2010) 1.99
Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol (2006) 1.94
Global prevalence and economic burden of urgency urinary incontinence: a systematic review. Eur Urol (2013) 1.83
The burden of depression in prostate cancer. Psychooncology (2011) 1.79
Impact of post-ejaculatory pain in men with category III chronic prostatitis/chronic pelvic pain syndrome. J Urol (2004) 1.76
Spermine oxidation induced by Helicobacter pylori results in apoptosis and DNA damage: implications for gastric carcinogenesis. Cancer Res (2004) 1.74
Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy. J Mol Cell Cardiol (2010) 1.73
Toremifene improves lipid profiles in men receiving androgen-deprivation therapy for prostate cancer: interim analysis of a multicenter phase III study. J Clin Oncol (2008) 1.72
Genetic deficiency of adiponectin protects against acute kidney injury. Kidney Int (2013) 1.71
Repeat prostate biopsy and the incremental risk of clinically insignificant prostate cancer. Urology (2011) 1.70
Interstitial fluorescence spectroscopy in the human prostate during motexafin lutetium-mediated photodynamic therapy. Photochem Photobiol (2007) 1.69
How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome? J Urol (2006) 1.68
Lower urinary tract symptoms revisited: a broader clinical perspective. Eur Urol (2008) 1.62
A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy. Int J Radiat Oncol Biol Phys (2012) 1.61
Nocturia Think Tank: focus on nocturnal polyuria: ICI-RS 2011. Neurourol Urodyn (2012) 1.56
Downregulation of cGMP-dependent protein kinase-1 activity in the corpus cavernosum smooth muscle of diabetic rabbits. Am J Physiol Regul Integr Comp Physiol (2004) 1.55
A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis. J Urol (2005) 1.54
Impact on renal function of percutaneous thermal ablation of renal masses in patients with preexisting chronic kidney disease. J Vasc Interv Radiol (2011) 1.54
The New England Research Institutes, Inc. (NERI) Nocturia Advisory Conference 2012: focus on outcomes of therapy. BJU Int (2013) 1.52
Racial differences in quality of life following prostate cancer diagnosis. Urology (2010) 1.51
Urodynamic studies in adults: AUA/SUFU guideline. J Urol (2012) 1.51
Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate. J Clin Oncol (2002) 1.47
Identification of clinically significant prostate cancer by prostate-specific antigen screening. Arch Intern Med (2004) 1.46
Contrasting effects of fish oil and safflower oil on hepatic peroxisomal and tissue lipid content. Am J Physiol Endocrinol Metab (2002) 1.46
Evaluation of perirenal fat as a predictor of cT 1a renal cortical neoplasm histopathology and surgical outcomes. J Endourol (2012) 1.44
Melanoma B16-F1 cells coated with fusion protein of mouse calreticulin and virus G-protein coupled receptor induced the antitumor immune response in Balb/C mice. Cancer Biol Ther (2011) 1.43
Vena caval transection during retroperitoneoscopic nephrectomy: report of the complication and review of the literature. J Urol (2004) 1.43
Cascaded discrimination of normal, abnormal, and confounder classes in histopathology: Gleason grading of prostate cancer. BMC Bioinformatics (2012) 1.42
Factors influencing the length of stay after radical cystectomy: implications for cancer care and perioperative management. Ann Surg Oncol (2014) 1.42
Enucleation of renal cell carcinoma with ablation of the tumour base. BJU Int (2008) 1.41
The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS. BJU Int (2009) 1.40
Association between utility and treatment among patients with prostate cancer. Qual Life Res (2010) 1.39
Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men. Cancer Epidemiol Biomarkers Prev (2005) 1.37
Anti-inflammatory and renal protective actions of stanniocalcin-1 in a model of anti-glomerular basement membrane glomerulonephritis. Am J Pathol (2009) 1.35
Determining histology-MRI slice correspondences for defining MRI-based disease signatures of prostate cancer. Comput Med Imaging Graph (2011) 1.28
Diffuse fibrous pseudotumor of the testicular tunics associated with an inflamed hydrocele. Arch Pathol Lab Med (2003) 1.27
Obstruction-induced changes in urinary bladder smooth muscle contractility: a role for Rho kinase. Am J Physiol Renal Physiol (2003) 1.27
Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigen. Clin Cancer Res (2008) 1.26
CXCL16 recruits bone marrow-derived fibroblast precursors in renal fibrosis. J Am Soc Nephrol (2011) 1.24
Digital pathology evaluation in the multicenter Nephrotic Syndrome Study Network (NEPTUNE). Clin J Am Soc Nephrol (2013) 1.24
Catastrophizing and pain-contingent rest predict patient adjustment in men with chronic prostatitis/chronic pelvic pain syndrome. J Pain (2006) 1.22
CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer. Cancer Res (2004) 1.21
Detrusor overactivity is associated with downregulation of large-conductance calcium- and voltage-activated potassium channel protein. Am J Physiol Renal Physiol (2010) 1.21
An active learning based classification strategy for the minority class problem: application to histopathology annotation. BMC Bioinformatics (2011) 1.20
Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence. Curr Opin Urol (2009) 1.19
Real-time in situ monitoring of human prostate photodynamic therapy with diffuse light. Photochem Photobiol (2007) 1.17
Cyclin D3/CDK11p58 complex is involved in the repression of androgen receptor. Mol Cell Biol (2007) 1.16
CCR2 mediates the uptake of bone marrow-derived fibroblast precursors in angiotensin II-induced cardiac fibrosis. Am J Physiol Heart Circ Physiol (2011) 1.14
Integrated diagnostics: a conceptual framework with examples. Clin Chem Lab Med (2010) 1.14
Critical role of CXCL16 in hypertensive kidney injury and fibrosis. Hypertension (2013) 1.13
UBIAD1 mutation alters a mitochondrial prenyltransferase to cause Schnyder corneal dystrophy. PLoS One (2010) 1.12
An interaction between apolipoprotein E and TERE1 with a possible association with bladder tumor formation. J Cell Biochem (2005) 1.12
Increased basal phosphorylation of detrusor smooth muscle myosin in alloxan-induced diabetic rabbit is mediated by upregulation of Rho-kinase beta and CPI-17. Am J Physiol Renal Physiol (2005) 1.12
Expression of the proto-oncogene Axl in renal cell carcinoma. DNA Cell Biol (2003) 1.12
Diabetes induced decrease in detrusor smooth muscle force is associated with oxidative stress and overactivity of aldose reductase. J Urol (2005) 1.12
Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance. Urol Oncol (2012) 1.12
Racial differences in medical mistrust among men diagnosed with prostate cancer. Cancer (2009) 1.11
Identification of IEX-1 as a biomechanically controlled nuclear factor-kappaB target gene that inhibits cardiomyocyte hypertrophy. Circ Res (2002) 1.10
Adiponectin promotes monocyte-to-fibroblast transition in renal fibrosis. J Am Soc Nephrol (2013) 1.09
Nuclear localization of human spermine oxidase isoforms - possible implications in drug response and disease etiology. FEBS J (2008) 1.08
Benign prostatic hyperplasia in primary care: what you need to know. J Urol (2006) 1.08
The bladder tumor suppressor protein TERE1 (UBIAD1) modulates cell cholesterol: implications for tumor progression. DNA Cell Biol (2011) 1.07
Experimental colitis triggers the release of substance P and calcitonin gene-related peptide in the urinary bladder via TRPV1 signaling pathways. Exp Neurol (2010) 1.07
Diagnosis and reconstruction of the dorsal or circumferential urethral diverticulum. J Urol (2003) 1.07
Evaluation of prostate cancer characteristics in four populations worldwide. Can J Urol (2008) 1.06
Alteration in expression of myosin isoforms in detrusor smooth muscle following bladder outlet obstruction. Am J Physiol Cell Physiol (2003) 1.06
Induction of the PAOh1/SMO polyamine oxidase by polyamine analogues in human lung carcinoma cells. Cancer Chemother Pharmacol (2003) 1.05
Ethnic variation in return to baseline values of patient-reported outcomes in older prostate cancer patients. Cancer (2007) 1.04
Are urodynamic tests useful tools for the initial conservative management of non-neurogenic urinary incontinence? A review of the literature. Eur Urol (2003) 1.03
CCR2 regulates the uptake of bone marrow-derived fibroblasts in renal fibrosis. PLoS One (2013) 1.02